Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: Review of 5,654 patients with an evaluable karyotype

Genes Chromosomes and Cancer

Volumn 52, Issue 8, 2013, Pages 753-763

  Costa, Dolors ^a   Muñoz, Concha ^a   Carrió, Ana ^a   Nomdedeu, Meritxell ^a   Calvo, Xavier ^a   Solé, Francesc ^b   Luño, Elisa ^c   Cervera, José ^d   Vallespí, Teresa ^e   Berneaga, Daniela ^a   Gómez, Cándida ^a   Arias, Amparo ^a   Such, Esperanza ^d   Sanz, Guillermo ^d   Grau, Javier ^f   Insunza, Andrés ^g   Calasanz, María J ^h   Ardañaz, María T ⁱ   Hernández, Jesús M ^j   Azaceta, Gemma ^k   Álvarez, Sara ^l   Sánchez, Joaquín ^m   Martín, María L ⁿ   Bargay, Joan ^o   Gómez, Valle ^p   Cervero, Carlos Javier ^q   Allegue, María J ^r   Collado, Rosa ^s   Campo, Elias ^a   Nomdedeu, Benet ^a   more..

^a HOSPITAL CLÍNIC   (Spain)

^b Institut Josep Carreres contra la leucemia   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^h UNIVERSITY OF NAVARRA   (Spain)

ⁱ HOSPITAL TXAGORRITXU   (Spain)

^j HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^k HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^l Structural Biology and Biocomputing Programme   (Spain)

^m HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁿ HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^o HOSPITAL SON LLÀTZER   (Spain)

^p HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^q HOSPITAL VIRGEN DE LA LUZ   (Spain)

^r Servicio de Hematología   (Spain)

^s HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; PROTEIN BCL 6; PROTEIN P53; TRANSCRIPTION FACTOR RUNX1;

ADULT; AGED; ARTICLE; CHROMOSOME ABERRATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE TRANSLOCATION; GENETIC ASSOCIATION; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; Y CHROMOSOME;

CHROMOSOMES, HUMAN; HUMANS; KARYOTYPE; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MYELODYSPLASTIC SYNDROMES; TRANSLOCATION, GENETIC;

EID: 84879256666     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22071     Document Type: Article

References (23)

1. Atlas of Genetics and Cytogenetics in Oncology and Haematology. Available at: http://atlasgeneticsoncology.org. Accessed on December, 2012.
2. Bejar R, Stevenson K, Abdel-Wahab O, Galili N, Nilsson B, Garcia-Manero G, Kantarjian H, Raza A, Levine RL, Neuberg D, Ebert BL. 2011. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 364:2496-2506.
3. Bloomfield CD, Archer KJ, Mrózek K, Lillington DM, Kaneko Y, Head DR, Dal Cin P, Raimondi SC. 2002. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 33:362-378.
4. Breems DA, Van Putten WL, De Greef GE, Van Zelderen-Bhola SL, Gerssen-Schoorl KB, Mellink CH, Nieuwint A, Jotterand M, Hagemeijer A, Beverloo HB, Löwenberg B. 2008. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 26:4791-4797.
5. Cui W, Sun J, Cotta CV, Medeiros LJ, Lin P. 2011.Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia. Am J Clin Pathol 136:282-288.
6. Han X, Medeiros LJ, Abruzzo LV, Jones D, Lin P. 2006. Chronic myeloproliferative diseases with the t(5;12)(q33;p13): Clonal evolution is associated with blast crisis. Am J Clin Pathol 125:49-56.
7. Heim S, Mitelman F. 2009. Cancer Cytogenetics, 3th ed. New Jersey: Wiley-Blackwell.
8. Horiike S, Misawa S, Nakai H, Kaneko H, Yokota S, Taniwaki M, Yamane Y, Inazawa J, Abe T, Kashima K. 1994. N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome. Leukemia 8:1331-1336.
9. Mitelman F, Johansson B, Mertens F, editors. 2012. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer http://cgap.nci.nih.gov/Chromosomes/Mitelman.
10. Nimer SD. 2008.Myelodysplastic syndromes. Blood 111:4841-4851.
11. Parikh SA, Tefferi A. 2012. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 87:610-619.
12. Pitini V, Arrigo C, Teti D, Barresi G, Righi M, Alo G. 2003. Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: A new case report. Haematologica 88:ECR18.
13. Raynaud SD, Baens M, Grosgeorge J, Rodgers K, Reid CDL, Dainton RM, Dyer M, Fuzibet, JG, Gratecos N, Taillan B, Ayraud N, Marynen P.1996. Fluorescence in situ hybridization analysis of t(3;12)(q26;p13): A recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. Blood 88:682-689.
14. Schanz J, Tüchler H, Solé F, Mallo M, Luño E, Cervera J, Granada I, Hildebrandt B, Slovak ML, Ohyashiki K, Steidl C, Fonatsch C, Pfeilstöcker M, Nösslinger T, Valent P, Giagounidis A, Aul C, Lübbert M, Stauder R, Krieger O, Garcia-Manero G, Faderl S, Pierce S, Le Beau MM, Bennett JM, Greenberg P, Germing U, Haase D. 2012. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol 30:820-829.
15. Schlegelberger B, Göhring G, Thol F, Heuser M. 2012. Update on cytogenetic and molecular changes in myelodysplastic syndromes. Leuk Lymphoma 53:525-536.
16. Shaffer LG, Slovak ML, Campbell LJ, editors. 2009. ISCN 2009: An International System for Human Cytogenetic Nomenclature. Basel: S. Karger.
17. Shin J, Kim M, Kim D-B, Yeom J-O, Lee H-J, Cho S-G. 2008. Sustained response to low-dose imatinib mesylate in a patient with chronic myelomonocytic leukemia with t(5;12)(q33;p13). Acta Haematol 119:57-59.
18. Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, Vardiman JW, Rowley JD, Larson RA. 2003. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 102:43-52.
19. Such E, Cervera J, Costa D, Solé F, Vallespí T, Luño E, Collado R, Calasanz MJ, Hernández-Rivas JM, Cigudosa JC, Nomdedeu B, Mallo M, Carbonell F, Bueno J, Ardanaz MT, Ramos F, Tormo M, Sancho-Tello R, del Cañizo C, Gómez V, Marco V, Xicoy B, Bonanad S, Pedro C, Bernal T, Sanz GF. 2011. Cytogenetic risk stratification in chronic myelomonocytic leukemia. Haematologica 96:375-383.
20. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Varidman JW, editors. 2008. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC.
21. Walker A, Mrózek K, Kohlschmidt J, Rao KW, Pettenati MJ, Sterling LJ, Marcucci G, Carroll AJ, Bloomfield CD; for the Alliance for Clinical Trials in Oncology. 2013. New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: Cancer and leukemia group B 8461. Genes Chromosomes Cancer 52:385-401.
22. Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF, Taniguchi T. 1993. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259:968-971.
23. Wlodarska I, Mecucci C, Marynen P, Guo C, Franckx D, La Starza R, Aventin A, Bosly A, Martelli MF, Cassiman JJ, Van den Berghe H. 1995. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). Blood 85:2848-2852.